Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eczema Atopic Dermatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00931411
What this trial is testing

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Cosmetique Active International 73
Testing effectiveness (Phase 2)Ended earlyNCT03809663
What this trial is testing

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 251
Not applicableStudy completedNCT02002871
What this trial is testing

Blue Light for Treating Eczema

Who this might be right for
Eczema
Philips Electronics Nederland BV 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Early research (Phase 1)Study completedNCT00891709
What this trial is testing

LEO 29102 Single and Multiple Dose Study by Dermal Application

Who this might be right for
Atopic Dermatitis
LEO Pharma 64
Not applicableStudy completedNCT03761199
What this trial is testing

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators

Who this might be right for
Quality of LifeAtopic Dermatitis
University School of Physical Education, Krakow, Poland 24
Testing effectiveness (Phase 2)Study completedNCT02975206
What this trial is testing

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Vyne Therapeutics Inc. 484
Early research (Phase 1)Study completedNCT02888704
What this trial is testing

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 13
Early research (Phase 1)Study completedNCT03514511
What this trial is testing

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 47
Large-scale testing (Phase 3)Study completedNCT03422822
What this trial is testing

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 3,166
Not applicableStudy completedNCT05140239
What this trial is testing

Effects of Abrocitinib Treatment on Skin Barrier Function

Who this might be right for
Atopic Dermatitis
Prof. Dr. Stephan Weidinger 20
Early research (Phase 1)Study completedNCT05034822
What this trial is testing

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 29
Not applicableStudy completedNCT04486742
What this trial is testing

Brief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in Eczema

Who this might be right for
Atopic Dermatitis
Northwestern University 20
Post-approval studies (Phase 4)Ended earlyNCT01231854
What this trial is testing

Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.

Who this might be right for
Atopic Dermatitis
Technische Universität Dresden 15
Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Large-scale testing (Phase 3)Ended earlyNCT03559270
What this trial is testing

Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 374
Testing effectiveness (Phase 2)Study completedNCT04212169
What this trial is testing

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AstraZeneca 148
Not applicableStudy completedNCT01164241
What this trial is testing

Natural History of Severe Allergic Inflammation and Reactions

Who this might be right for
PGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR Deficiency+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 945
Very early researchStudy completedNCT05372003
What this trial is testing

IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mayo Clinic 7
Early research (Phase 1)Study completedNCT01065272
What this trial is testing

Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma

Who this might be right for
Bronchiolitis
Hamad Medical Corporation 200
Next Page